John C Probasco
Overview
Explore the profile of John C Probasco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1066
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Habis R, Kolchinski A, Heck A, Bean P, Probasco J, Hasbun R, et al.
Clin Infect Dis
. 2025 Mar;
PMID: 40045564
No abstract available.
2.
Quinn C, Rajarajan P, Gill A, Kopinsky H, Wolf A, de Camargo C, et al.
Neurology
. 2024 Nov;
103(11):e210003.
PMID: 39541548
Background And Objectives: Immune checkpoint inhibitors (ICIs) are increasingly used against various cancers but are associated with immune-related adverse events (irAEs). Risk of irAEs may be higher in patients with...
3.
Habis R, Kolchinski A, Heck A, Bean P, Probasco J, Hasbun R, et al.
Clin Infect Dis
. 2024 Nov;
PMID: 39541430
No abstract available.
4.
Habis R, Kolchinski A, Heck A, Bean P, Probasco J, Hasbun R, et al.
Clin Infect Dis
. 2024 Aug;
PMID: 39096271
Background: Early diagnosis of encephalitis involves identifying signs of neuroinflammation, including cerebrospinal fluid (CSF) pleocytosis. However, absence of CSF pleocytosis in encephalitis has been described, most notably in autoimmune encephalitis....
5.
Buckley M, Balaji Warner A, Brahmer J, Cappelli L, Sharfman W, Fuchs E, et al.
Oncologist
. 2024 Jul;
30(1).
PMID: 39066587
Background: Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but can trigger immune-related encephalitis. We report one of the largest case series of patients with immune-related encephalitis and review of...
6.
Krett J, Molinaro M, McArthur J, Kamson D, Green K, Probasco J
Neurohospitalist
. 2024 Jun;
14(3):363-365.
PMID: 38895007
Herein we describe a case of relapsing anti-GAD65-associated encephalitis which was responsive to the combination of thymoma resection, external beam radiotherapy, and immunomodulatory therapy. The case illustrates the value of...
7.
Crowe E, Diaz-Arias L, Habis R, Vozniak S, Geocadin R, Venkatesan A, et al.
J Clin Apher
. 2024 Apr;
39(3):e22112.
PMID: 38634442
Introduction: Autoimmune encephalitis (AE) comprises a heterogeneous group of autoantibody-mediated disorders targeting the brain parenchyma. Therapeutic plasma exchange (TPE), one of several first-line therapies for AE, is often initiated when...
8.
Roman S, Sadaghiani M, Diaz-Arias L, Le Marechal M, Venkatesan A, Solnes L, et al.
Ann Clin Transl Neurol
. 2024 Mar;
11(5):1211-1223.
PMID: 38453690
Objective: Brain F-FDG PET/CT is a useful diagnostic in evaluating patients with suspected autoimmune encephalitis (AE). Specific patterns of brain dysmetabolism have been reported in anti-NMDAR and anti-LGI1 AE, and...
9.
Crane M, Nair-Desai S, Gemmill A, Romley J, Probasco J
JAMA Neurol
. 2023 Dec;
81(2):195-197.
PMID: 38079182
No abstract available.
10.
Sadaghiani M, Roman S, Diaz-Arias L, Habis R, Venkatesan A, Probasco J, et al.
Neuroradiology
. 2023 Jun;
65(8):1225-1238.
PMID: 37264220
Objectives: Anti-leucine glioma-inactivated protein 1 (anti-LGI1) autoimmune encephalitis (AE) presents as subacute memory loss, behavioral changes, and seizures. Diagnosis and treatment delays can result in long term sequelae, including cognitive...